POZEN Inc. announced that Scott Charles will be appointed Senior Vice President of Finance of the company, effective July 27, 2015. upon completion of the pending merger of the company with Tribute Pharmaceuticals Canada Inc. Mr. Charles will report to Adrian Adams, Chief Executive Officer of the company, and will be responsible for all financial activities related to the integration of Tribute Pharmaceuticals upon its anticipated merger with POZEN and with respect to the implementation of all systems necessary for the planned transformation of POZEN and ultimately Aralez Pharmaceuticals into a commercial specialty pharmaceuticals company. He will also play a critical role on the leadership team.